NMC
CBIO
NEA Management Company’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-3,835,039
| Closed | -$11.5M | – | 42 |
|
2024
Q1 | $11.5M | Sell |
3,835,039
-929,401
| -20% | -$2.79M | 0.71% | 27 |
|
2023
Q4 | $11.2M | Hold |
4,764,440
| – | – | 0.75% | 27 |
|
2023
Q3 | $7.15M | Hold |
4,764,440
| – | – | 0.55% | 29 |
|
2023
Q2 | $8.29M | Hold |
4,764,440
| – | – | 0.63% | 29 |
|
2023
Q1 | $6M | Sell |
4,764,440
-4,203,266
| -47% | -$5.3M | 0.42% | 33 |
|
2022
Q4 | $27.2M | Sell |
8,967,706
-121,335
| -1% | -$368K | 1.53% | 17 |
|
2022
Q3 | $5.01M | Hold |
9,089,041
| – | – | 0.25% | 43 |
|
2022
Q2 | $5.43M | Hold |
9,089,041
| – | – | 0.28% | 42 |
|
2022
Q1 | $10.4M | Hold |
9,089,041
| – | – | 0.3% | 40 |
|
2021
Q4 | $13.1M | Hold |
9,089,041
| – | – | 0.26% | 41 |
|
2021
Q3 | $19.9M | Hold |
9,089,041
| – | – | 0.24% | 38 |
|
2021
Q2 | $21.1M | Hold |
9,089,041
| – | – | 0.27% | 41 |
|
2021
Q1 | $27.4M | Hold |
9,089,041
| – | – | 0.61% | 35 |
|
2020
Q4 | $34.2M | Hold |
9,089,041
| – | – | 0.9% | 27 |
|
2020
Q3 | $27.9M | Hold |
9,089,041
| – | – | 1.18% | 22 |
|
2020
Q2 | $34.2M | Hold |
9,089,041
| – | – | 1.37% | 19 |
|
2020
Q1 | $20.7M | Hold |
9,089,041
| – | – | 1.08% | 20 |
|
2019
Q4 | $48.1M | Hold |
9,089,041
| – | – | 2.27% | 15 |
|
2019
Q3 | $39.2M | Hold |
9,089,041
| – | – | 3.24% | 9 |
|
2019
Q2 | $108M | Hold |
9,089,041
| – | – | 7.59% | 2 |
|
2019
Q1 | $113M | Hold |
9,089,041
| – | – | 5.88% | 4 |
|
2018
Q4 | $86.1M | Hold |
9,089,041
| – | – | 3.41% | 7 |
|
2018
Q3 | $131M | Hold |
9,089,041
| – | – | 5.65% | 5 |
|
2018
Q2 | $147M | Buy |
9,089,041
+504,913
| +6% | +$8.14M | 6.87% | 4 |
|
2018
Q1 | $139M | Hold |
8,584,128
| – | – | 6.2% | 4 |
|
2017
Q4 | $144M | Hold |
8,584,128
| – | – | 5.97% | 2 |
|
2017
Q3 | $120M | Hold |
8,584,128
| – | – | 4.21% | 4 |
|
2017
Q2 | $95.8M | Hold |
8,584,128
| – | – | 3.49% | 5 |
|
2017
Q1 | $46.6M | Hold |
8,584,128
| – | – | 1.62% | 11 |
|
2016
Q4 | $52.4M | Hold |
8,584,128
| – | – | 2.08% | 10 |
|
2016
Q3 | $61.4M | Hold |
8,584,128
| – | – | 2.75% | 9 |
|
2016
Q2 | $62.4M | Hold |
8,584,128
| – | – | 3.24% | 8 |
|
2016
Q1 | $51.2M | Buy |
8,584,128
+10
| +0% | +$60 | 3.4% | 9 |
|
2015
Q4 | $49.1M | Buy |
8,584,118
+8,983
| +0.1% | +$51.4K | 3.13% | 9 |
|
2015
Q3 | $48M | Hold |
8,575,135
| – | – | 3.16% | 10 |
|
2015
Q2 | $68.2M | Hold |
8,575,135
| – | – | 3.56% | 8 |
|
2015
Q1 | $71.3M | Hold |
8,575,135
| – | – | 3.23% | 10 |
|
2014
Q4 | $61.7M | Hold |
8,575,135
| – | – | 2.99% | 10 |
|
2014
Q3 | $59.5M | Hold |
8,575,135
| – | – | 3.02% | 10 |
|
2014
Q2 | $72.3M | Hold |
8,575,135
| – | – | 3.39% | 10 |
|
2014
Q1 | $140M | Buy |
+8,575,135
| New | +$140M | 6.87% | 6 |
|